These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 643163

  • 21. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK.
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Hyperpolarizing action of baclofen on neurons in the rat substantia nigra slice.
    Pinnock RD.
    Brain Res; 1984 Nov 26; 322(2):337-40. PubMed ID: 6509322
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH, Korf J.
    Eur J Pharmacol; 1976 Nov 26; 40(1):131-6. PubMed ID: 991922
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of baclofen and haloperidol on gamma-aminobutyric acid and dopamine systems in an animal model of tardive dyskinesia.
    Rastogi SK, Rastogi RB, Lapierre YD, Singhal RL.
    Gen Pharmacol; 1982 Nov 26; 13(6):499-504. PubMed ID: 7152230
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Proceedings: Behavioral effects of direct and indirect acting dopaminergic agonists.
    Moore KE.
    Psychopharmacol Bull; 1974 Jul 26; 10(3):41-2. PubMed ID: 4419323
    [No Abstract] [Full Text] [Related]

  • 32. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM.
    Eur J Pharmacol; 1980 Jun 13; 64(2-3):123-32. PubMed ID: 6105080
    [Abstract] [Full Text] [Related]

  • 33. gamma-Aminobutyric acid: the essential mediator of behaviour triggered by neostriatally applied apomorphine and haloperidol.
    Cools AR, Janssen HJ.
    J Pharm Pharmacol; 1976 Jan 13; 28(1):70-4. PubMed ID: 6658
    [No Abstract] [Full Text] [Related]

  • 34. Comparative involvement of dopamine and noradrenaline in rate-free self-stimulation in substania nigra, lateral hypothalamus, and mesencephalic central gray.
    Liebman JM, Butcher LL.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Jan 13; 284(2):167-94. PubMed ID: 4152814
    [No Abstract] [Full Text] [Related]

  • 35. Increase in mouse brain dopamine content by baclofen: effects of apomorphine and neuroleptics.
    Gianutsos G, Moore KE.
    Psychopharmacology (Berl); 1977 May 09; 52(3):217-21. PubMed ID: 406622
    [Abstract] [Full Text] [Related]

  • 36. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A, Bruno F, Cattabeni F, Groppetti A, Parenti M, Racagni G.
    Brain Res; 1978 Apr 21; 145(1):180-4. PubMed ID: 205324
    [No Abstract] [Full Text] [Related]

  • 37. Effect of dopamine agonists on gamma-aminobutyric acid (GABA) turnover in the superior colliculus: evidence that nigrotectal GABA projections are under the influence of dopaminergic transmission.
    Melis MR, Gale K.
    J Pharmacol Exp Ther; 1983 Aug 21; 226(2):425-31. PubMed ID: 6875856
    [Abstract] [Full Text] [Related]

  • 38. Circling behaviour in the rat following unilateral injections of p-chlorophenylalanine and ethanolamine-O-sulphate into the substantia nigra.
    Tanner T.
    J Pharm Pharmacol; 1978 Mar 21; 30(3):158-61. PubMed ID: 24688
    [Abstract] [Full Text] [Related]

  • 39. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD, Creese I.
    Adv Neurol; 1975 Mar 21; 9():81-92. PubMed ID: 1170717
    [No Abstract] [Full Text] [Related]

  • 40. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
    Hudson JL, van Horne CG, Strömberg I, Brock S, Clayton J, Masserano J, Hoffer BJ, Gerhardt GA.
    Brain Res; 1993 Oct 29; 626(1-2):167-74. PubMed ID: 8281427
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.